No more excuses, Dr. Fauci.
The FDA staff has endorsed the Johnson & Johnson single-shot COVID-19 vaccine for emergency use after a trial on 44,000 patients.
If approved, the market will have three COVID-19 vaccines.
The trial took place in the U.S., South Africa, and other countries. It resulted in “seven COVID-19 deaths among patients getting a placebo, and none among those who got a vaccine.”
Details: The shot was found to be 66.9% effective against moderate to severe COVID-19 cases 14 days after vaccination, and 66.1% effective after 28 days. Against severe to critical cases, the vaccine was 76.6% effective after 14 days and 85.4% effective after 28 days.
- A large clinical trial showed no COVID-19 hospitalizations or deaths 28 days after patients received the vaccine.
- “The analysis supported a favorable safety profile with no specific safety concerns identified that would preclude issuance of an EUA,” FDA staff wrote.
The advisory panel will meet on Friday to review the data. They will then vote whether to recommend the vaccine for emergency use. The notice could come this weekend.
Johnson & Johnson believes it could have around 20 million doses by the end of March. It projects it will deliver 100 million doses in the U.S. by the end of June and over a billion across the world.
Pfizer and Moderna, which have two-dose vaccines, hope to have enough to vaccinate 100 million people by the end of March. The companies want to vaccinate 300 million in the U.S. by the end of July.
America’s population is 382.2 million people.
With that data, Dr. Anthony Fauci and other government officials can finally stop keeping us hostage. There is no excuse to stay locked up and denied the simple pleasures of life.
Also, get your flu shot. Get your pneumonia shot if you qualify.DONATE
Donations tax deductible
to the full extent allowed by law.